The following data is part of a premarket notification filed by Oncospace, Inc. with the FDA for Oncospace.
| Device ID | K202284 |
| 510k Number | K202284 |
| Device Name: | Oncospace |
| Classification | System, Planning, Radiation Therapy Treatment |
| Applicant | Oncospace, Inc. 1812 Ashland Ave., Suite 100k Baltimore, MD 21205 |
| Contact | Praveen Sinha |
| Correspondent | Praveen Sinha Oncospace, Inc. 1812 Ashland Ave., Suite 100k Baltimore, MD 21205 |
| Product Code | MUJ |
| CFR Regulation Number | 892.5050 [🔎] |
| Decision | Substantially Equivalent (SESE) |
| Type | Traditional |
| 3rd Party Reviewed | No |
| Combination Product | No |
| Date Received | 2020-08-12 |
| Decision Date | 2021-03-12 |
| Device Identifier | submissionNumber | Supplement |
|---|---|---|
| 00860004284901 | K202284 | 000 |
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
![]() ONCOSPACE 88367961 not registered Live/Pending |
Oncospace, Inc. 2019-04-02 |
![]() ONCOSPACE 86875076 not registered Dead/Abandoned |
The Johns Hopkins University 2016-01-14 |
![]() ONCOSPACE 85495019 not registered Dead/Abandoned |
The Johns Hopkins University 2011-12-14 |
![]() ONCOSPACE 76324347 not registered Dead/Abandoned |
PHARMACIA ENTERPRISES S.A. 2001-10-11 |